# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
electroCore (NASDAQ:ECOR) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.44) b...
- SEC Filing
electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, is thrilled to announce the Co...
electroCore (NASDAQ:ECOR) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.61) b...
electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has re...